Crinetics Pharmaceuticals logo

Crinetics Pharmaceuticals share price today

(CRNX)

Crinetics Pharmaceuticals share price is $53.6 & ₹4,554.71 as on 21 Dec 2024, 2.30 'hrs' IST

$53.6

0.86

(1.63%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Crinetics Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Crinetics Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Crinetics Pharmaceuticals. Get details on the Indian mutual funds that are investing in Crinetics Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Crinetics Pharmaceuticals's financials.

Crinetics Pharmaceuticals share price movements

  • Today's Low: $51.75
    Today's High: $54.22

    Day's Volatility :4.56%

  • 52 Weeks Low: $33.67
    52 Weeks High: $62.53

    52 Weeks Volatility :46.15%

Crinetics Pharmaceuticals Returns

PeriodCrinetics Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
6.31%
-11.1%
0.0%
6 Months
17.39%
-6.0%
0.0%
1 Year
49.26%
2.7%
0.0%
3 Years
106.47%
0.6%
-19.7%

Crinetics Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$52.74
Open
$52.28
Today's High
$54.22
Today's Low
$51.75
Market Capitalization
$4.9B
Today's Volume
$1.6M
52 Week High
$62.53
52 Week Low
$33.67
Revenue TTM
$1.0M
EBITDA
$-304.5M
Earnings Per Share (EPS)
$-3.7
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-40.26%

How to invest in Crinetics Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Crinetics Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Crinetics Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Crinetics Pharmaceuticals or CRNX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Crinetics Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Crinetics Pharmaceuticals shares which would translate to 0.016 fractional shares of Crinetics Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Crinetics Pharmaceuticals, in just a few clicks!

Returns in Crinetics Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Crinetics Pharmaceuticals investment value today

Current value as on today

₹1,51,458

Returns

₹51,458

(+51.46%)

Returns from Crinetics Pharmaceuticals Stock

₹49,262 (+49.26%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Crinetics Pharmaceuticals

500%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Crinetics Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 500% more investors are searching Crinetics Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Crinetics Pharmaceuticals

  • Vanguard Group Inc

    6.78%

  • BlackRock Inc

    6.72%

  • Driehaus Capital Management LLC

    6.35%

  • T. Rowe Price Associates, Inc.

    5.33%

  • Wellington Management Company LLP

    4.81%

  • FMR Inc

    4.80%

Analyst Recommendation on Crinetics Pharmaceuticals

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 20 Wall street analysts offering stock ratings for Crinetics Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 20 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
18
18
17
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Crinetics Pharmaceuticals

What analysts predicted

Upside of 38.06%

Current:

$53.60

Target:

$74.00

Insights on Crinetics Pharmaceuticals

  • Price Movement

    In the last 3 years, CRNX stock has moved up by 104.7%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 640.0K → 399.0K (in $), with an average decrease of 37.7% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 9 quarters, -40.39M → -76.82M (in $), with an average decrease of 8.5% per quarter

Crinetics Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Crinetics Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Crinetics Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Crinetics Pharmaceuticals Inc
-6.01%
17.39%
49.26%
106.47%
136.23%
Regeneron Pharmaceuticals, Inc.
-5.73%
-34.03%
-17.11%
13.66%
87.56%
Biontech Se
4.48%
30.56%
7.36%
-56.46%
225.6%
Alnylam Pharmaceuticals, Inc.
-0.55%
10.11%
28.49%
30.99%
109.19%
Vertex Pharmaceuticals Incorporated
-11.79%
-16.36%
-1.97%
78.33%
80.59%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Crinetics Pharmaceuticals Inc
NA
NA
NA
-3.71
-0.4
-0.24
NA
10.3
Regeneron Pharmaceuticals, Inc.
17.51
17.51
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.17
0.55
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Crinetics Pharmaceuticals Inc
Buy
$4.9B
136.23%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$77.8B
87.56%
17.51
33.61%
Biontech Se
Buy
$26.7B
225.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.8B
109.19%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$102.1B
80.59%
32.84
-4.51%

Crinetics Pharmaceuticals Dividend announcements

  • Crinetics Pharmaceuticals Earnings

    Crinetics Pharmaceuticals’s price-to-earnings ratio stands at None

    Read More

About Crinetics Pharmaceuticals

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.
Organization
Crinetics Pharmaceuticals
Employees
290
CEO
Dr. R. Scott Struthers Ph.D.
Industry
Health Technology

Management People of Crinetics Pharmaceuticals

NameTitle
Dr. R. Scott Struthers Ph.D.
Founder, President, CEO & Director
Dr. Stephen F. Betz Ph.D.
Founder & Chief Scientific Officer
Mr. Marc J. C. Wilson CPA
Chief Financial Officer
Mr. Jeff E. Knight
Chief Operating Officer
Dr. Alan S. Krasner M.D.
Chief Endocrinologist
Gayathri Diwakar
Head of Investor Relations
Ms. Garlan Adams
General Counsel & Corporate Secretary
Ms. Adriana Cabre M.B.A.
Chief Human Resources Officer
Mr. Kevin Capps
Head of Intellectual Property
Mr. Chris Robillard M.B.A.
Chief Business Officer

Important FAQs about investing in Crinetics Pharmaceuticals from India :

What is Crinetics Pharmaceuticals share price today?

Crinetics Pharmaceuticals share price today stands at $53.60, Open: $52.28 ; Previous Close: $52.74 ; High: $54.22 ; Low: $51.75 ; 52 Week High: $62.53 ; 52 Week Low: $33.67. The stock opens at $52.28, after a previous close of $52.74. The stock reached a daily high of $54.22 and a low of $51.75, with a 52-week high of $62.53 and a 52-week low of $33.67.

Can Indians buy Crinetics Pharmaceuticals shares?

Yes, Indians can invest in the Crinetics Pharmaceuticals (CRNX) from India.

With INDmoney, you can buy Crinetics Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Crinetics Pharmaceuticals at zero transaction cost.

How can I buy Crinetics Pharmaceuticals shares from India?

It is very easy to buy Crinetics Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Crinetics Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Crinetics Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Crinetics Pharmaceuticals stocks?

To start investing in Crinetics Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Crinetics Pharmaceuticals

Today’s highest price of Crinetics Pharmaceuticals (CRNX) is $54.22.

Today’s lowest price of Crinetics Pharmaceuticals (CRNX) is $51.75.

What is today's market capitalisation of Crinetics Pharmaceuticals

Today's market capitalisation of Crinetics Pharmaceuticals CRNX is 4.9B

What is the 52 Week High and Low Range of Crinetics Pharmaceuticals

  • 52 Week High

    $62.53

  • 52 Week Low

    $33.67

What are the historical returns of Crinetics Pharmaceuticals?

  • 1 Month Returns

    -6.01%

  • 3 Months Returns

    17.39%

  • 1 Year Returns

    49.26%

  • 5 Years Returns

    136.23%

Who is the Chief Executive Officer (CEO) of Crinetics Pharmaceuticals

Dr. R. Scott Struthers Ph.D. is the current Chief Executive Officer (CEO) of Crinetics Pharmaceuticals.